Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)

Trial Centre Location Province Status
CancerCare Manitoba Winnipeg Manitoba Closed
Dr. Léon Richard Oncology Centre Moncton New Brunswick Closed
Durham Regional Cancer Centre Oshawa Ontario Closed
Hamilton Health Sciences Hamilton Ontario Closed
London Health Sciences Centre London Ontario Closed
St. Catharines General Hospital At Niagara Health System St. Catharines Ontario Closed
William Osler Health Centre Brampton Ontario Closed
CHAU Hôtel-Dieu de Lévis Levis Quebec Closed
CIUSSS de l'Est de l'Ile-de-Montréal - Hôpital Maisonneuve-Rosemont Montreal Quebec Closed
CIUSSS du Saguenay Lac-St-Jean - Hôpital de Chicoutimi Chicoutimi Quebec Closed
Allan Blair Cancer Centre Regina Saskatchewan Closed
Saskatoon Cancer Centre Saskatoon Saskatchewan Closed

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society